Nosocomial bloodstream infections: Organisms, risk factors and resistant phenotypes in the Brazilian University Hospital

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 3, 2007, Pages 351-354

  Ribas, Rosineide M ^a,b   Freitas, Claudete ^a   Filho, Paulo P Gontijo ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Nosocomial bacteremia; Resistance phenotypes; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE AMPC; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; METICILLIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BRAZIL; CONTROLLED STUDY; DEVICE INFECTION; DRUG USE; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PANTOEA AGGLOMERANS; PHENOTYPE; PREVALENCE; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION;

EID: 35448997401     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000300010     Document Type: Article

References (22)

1. Correa L., Pittet D. Problems and solutions in hospital-acquired bacteremia. J Hosp Infect 2000;46:89-95.
2. Maki D.G., Mermel L.A. Infections due to Infusion Therapy. In: Bennett J.V., Brachman P.S. (eds). Hospital Infections. Lippincott-Raven, Washington, 1998, p. 689-724.
3. Moellering, R.C. Jr. Antibiotic resistance: Lessons for the future. Clin Infect Dis 1998;27(suppl.1):135-40.
4. Peña C., Pujol M., Ardanuy C., et al. An outbreak of hospital-acquired Klebsiella pneumoniae, including strains producing extended- spectrum Beta-Lactamase. J Hosp Infect 2001; 47:53-9.
5. NCCLS 2001. Performance Standards for Antimicrobial Susceptibility Testing; Eleventh Informational Supplement. NCCLS document M100-S11. Wayne, PA:National Committee for Clinical Laboratory Standards, 2001.
6. Dean A.G, Dean J.A., Burton, A.H. Epi-Info, version 5.0: A word processing database and statistics program for epidemiologu on microcomputers. Storie Mountain GA., USD. Ins. 1990.
7. Goldmann D.A., Huskins W.C. Control of Nosocomial Antimicrobial-Resistance bacteria: A strategic priority for Hospital worldwide. Clin Infect Dis 1997;24(suppl 1):S139-S45.
8. Vincent J.L. Nosocomial infections in adult intensive-care units. The Lancet 2003;361:2068-77.
9. Richards M.J., Edwards F.R., Culver D.H., Gaynes R.F. Nosocomial infections in combined medical-surgical intensive care units in the United. States. Infect Control Hosp Epidemiol 2000; 21:510-5.
10. Weinstein R.A. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. E Infect Dis 2001; 7:188-92.
11. Hanberger H., Diekema D., Fluit A., et al. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 2001:48:161-76.
12. Guzman-Blanco M., Casellas, J.M., Sader H.S. Bacterial resistance to antimicrobial agents in Latin America. Infect Dis Clin North Am 2000; 14:67-81.
13. Diekema D.J., Pfaller M.A., Schmitz F.J., et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates coleted in the United States, Canada, Latin America, Eurupe and the Western Pacific for the SENTRY Antimicrobial Surveillance Program. Clin Infec Dis 1997-1999; 32(Suppl. 2):S114-S32.
14. Dalla Costa L.M., Souza D.C., Martins L.T.F. et al. Vancomycin resistant Enterococcus faecium: first case in Brazil. Braz J Infect Dis 1998;2:160-3.
15. Sader H.S. Vancomycin-resistant enterococci has finally arrived in South America. MicroNews Alert CMC-API. Publication del Comité de Microbiologia Clinica de API., 1998;1:3.
16. Cereda R., Pignatari A.C., Hashimoto A., et al. In vitro antimicrobial activity against enterococci-isolated in a University Hospital in São Paulo-Brazil. J Infect Dis 1997;1:83-90.
17. d'Azevedo P.A. Diversidade fenotípica e genotípica de Enterococcus isolados em porto Alegre. Rio Grande do Sul. Tese de Doutorado. Rio de Janeiro, 123p, 2001.
18. Thomson K.S., Prevan A.M., Sanders C.C. Novel plasmid-mediated Beta-lactamases in Enterobacteriaceae: emerging problems for new Beta-lactam antibiotics. Curr Clin Top Infect Dis 1996;16:151-63.
19. Sader H.S., Gales A.C., Pfaller M.A., et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 2001;4:200-214.
20. Pitout J. D., Moland E.S., Sanders C.C., et al. Beta-Lactamases and detection of Beta-Lactam resistance in Enterobacter spp. Antimicrob Agents Chemother 1997;41:35-9.
21. Darouiche R.O. Device-associated infections: A macroproblem that starts with microadherence. Health Epidemiol 2001;33:1567-72.
22. Paterson D.L., Bonomo R.A., Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Reviews 2005;18:657-86.